Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany
Dr. Samatoshenkov Igor Valeryevich is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉
Publication Profile
Scopus
ORCID
🎓 Education Background
Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺
💼 Professional Experience
Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡
🏆 Awards and Honors
Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬
🔬 Research Focus
Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠
🔚 Conclusion
With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐
📘 Top Publications
-
Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
Authors: I.V. Samatoshenkov, B.M. Mirolyubov
Cited by: —
Journal Link: Not publicly available online
-
Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
Cited by: 5+
-
Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
Authors: I.V. Samatoshenkov et al.
🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
Cited by: 10+
-
Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
🔗 https://doi.org/10.34922/AE.2020.157.1.006
Cited by: 15+
-
Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
Authors: I.V. Samatoshenkov et al.
🔗 https://doi.org/10.1007/s12668-019-00688-y
Cited by: 25+
-
New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
Authors: Igor Samatoshenkov et al.
🔗 https://doi.org/10.1016/j.mvr.2022.104425
Cited by: 8+
-
Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
🔗 https://doi.org/10.3390/cimb46080507
Cited by: 12+